Home
E-submission
Sitemap
Contact us
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
FOR CONTRIBUTORS
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
How to cite this journal?
Permission request
Search
Intest Res Search
CLOSE
Search
Page Path
HOME
Search
IBD
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies
Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, Tadakazu Hisamatsu, Fumihito Hirai, Joe Milata, Xingyuan Li, Nathan Morris, Vipin Arora, Tomoko Ishizuka, Koji Matsuo, Yoichi Satoi, Catherine Milch, Toshifumi Hibi
Intest Res.
2024;22(2):172-185.
Published online April 25, 2024
DOI:
https://doi.org/10.5217/ir.2023.00043
Full text
PubReader
ePub
PDF
Supplementary Material
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
Intest Res.
2022;20(4):475-481.
Published online June 13, 2022
DOI:
https://doi.org/10.5217/ir.2021.00142
Web of Science 5
Crossref 5
Full text
PubReader
ePub
PDF
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe
Intest Res.
2023;21(1):110-125.
Published online March 11, 2022
DOI:
https://doi.org/10.5217/ir.2021.00143
Web of Science 10
Crossref 10
Full text
PubReader
ePub
PDF
Supplementary Material
Inflammatory Bowel Diseases
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2021;19(4):408-418.
Published online November 20, 2020
DOI:
https://doi.org/10.5217/ir.2020.00025
Web of Science 17
Crossref 13
Full text
PubReader
ePub
PDF
Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
Intest Res.
2021;19(4):419-429.
Published online November 10, 2020
DOI:
https://doi.org/10.5217/ir.2020.00033
Web of Science 12
Crossref 13
Full text
PubReader
ePub
PDF
Inflammatory bowel diseases
Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry
Katsuhiro Arai, Reiko Kunisaki, Fumihiko Kakuta, Shin-ichiro Hagiwara, Takatsugu Murakoshi, Tadahiro Yanagi, Toshiaki Shimizu, Sawako Kato, Takashi Ishige, Tomoki Aomatsu, Mikihiro Inoue, Takeshi Saito, Itaru Iwama, Hisashi Kawashima, Hideki Kumagai, Hitoshi Tajiri, Naomi Iwata, Takahiro Mochizuki, Atsuko Noguchi, Toshihiko Kashiwabara, Hirotaka Shimizu, Yasuo Suzuki, Yuri Hirano, Takeo Fujiwara
Intest Res.
2020;18(4):412-420.
Published online August 18, 2020
DOI:
https://doi.org/10.5217/ir.2019.00130
Web of Science 18
Crossref 20
Full text
PubReader
ePub
PDF
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study
Masayuki Saruta, Dong Il Park, Young-Ho Kim, Suk-Kyun Yang, Byung-Ik Jang, Jae Hee Cheon, Jong Pil Im, Takanori Kanai, Tatsuro Katsuno, Yoh Ishiguro, Makoto Nagaoka, Naoki Isogawa, Yinhua Li, Anindita Banerjee, Alaa Ahmad, Mina Hassan-Zahraee, Robert Clare, Kenneth J. Gorelick, Fabio Cataldi, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2020;18(1):45-55.
Published online January 30, 2020
DOI:
https://doi.org/10.5217/ir.2019.00039
Web of Science 7
Crossref 6
Full text
PubReader
ePub
PDF
Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
Intest Res.
2019;17(3):375-386.
Published online February 12, 2019
DOI:
https://doi.org/10.5217/ir.2018.00141
Web of Science 15
Crossref 14
Full text
PubReader
ePub
PDF
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
Intest Res.
2017;15(4):475-486.
Published online October 23, 2017
DOI:
https://doi.org/10.5217/ir.2017.15.4.475
Web of Science 18
Crossref 20
Full text
PubReader
ePub
PDF
Supplementary Material
1
Journal Impact Factor 3.4
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
AUTHOR INFORMATION
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?